加入收藏 欢迎光临Abbkine Scientific Co., Ltd官方网站全国服务热线:400-6800-830
登录 注册
中文

亚科因(Abbkine)—服务于细胞和蛋白研究全球用户

货号 产品名称 文献标题 IF 杂志名称
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Formononetin ameliorates depression-like behaviors through rebalancing microglia M1/M2 polarization and inhibiting NLRP3 inflammasome: involvement of activating PPARα-mediated autophagy. 6.400 Molecular Medicine 
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Modular Assembly of Heterotrifunctional Molecules Enabled by Iodosulfonylation of Allenes and Subsequent Amination. 7 Journal of Medicinal Chemistry
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) PPP2R1A silencing suppresses LUAD progression by sensitizing cells to nelfinavir-induced apoptosis and pyroptosis. 5 Cancer Cell International
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Exploring the protective mechanisms of syringaresinol against myocardial infarction by experimental validation and network pharmacology.  Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Catalytic and biological properties of Ag–Pt bimetallic nanoparticles: composition-dependent activity and cytotoxicity. 5.100 Nanoscale 
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1. 2 Fan, Chenyang, et al.
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) CCT196969 inhibits TNBC by targeting the HDAC5/RXRA/ASNS axis to down-regulate asparagine synthesis.
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Targeted inhibition of NEK7 preventing sepsis-induced cardiomyopathy by inhibiting NLRP3 inflammasome. 4.700 International Immunopharmacology 
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Targeting the poliovirus receptor to activate T cells and induce myeloid-derived suppressor cells to differentiate to pro-inflammatory macrophages via the IFN-γ-p-STAT1-IRF8 axis in cancer therapy. 15  Cell Death & Differentiation 
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Sap30bp Aggravates Mitochondrial-Related Ferroptosis in Diabetic Cardiomyopathy by Regulating Mfn2-Acsl4 Axis.
意见反馈
在线咨询
扫码关注

微信公众号

返回顶部